Discover 927 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 927
Active & Responsive
Cannabis and Opioid Use Disorder
for
Opioid Use Disorder
Location: Lexington KY
Sponsor: University of Kentucky
Sex: All
Age: 18 - 55
Code: NCT05729932
Phase1, Recruiting
Active & Responsive
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Louisville KY, Huntersville NC, Grand Rapids MI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06750185
Phase1, Recruiting
Active & Responsive
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
for
Colonic Neoplasms, Neoplasms, Colon
Location: Lexington KY, Cincinnati OH, Akron OH, St Louis MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05855200
Phase3, Recruiting
Active & Responsive
The Effects of Sex Hormones and Alcohol on Sleep
for
Alcohol Use Disorder
Location: Lexington KY
Sponsor: Lauren Whitehurst
Sex: All
Age: 21 - 45
Code: NCT06143059
Phase3, Recruiting
Active & Responsive
A Study of Barzolvolimab in Patients With Atopic Dermatitis
for
Atopic Dermatitis
Location: Cincinnati OH, Bowling Green KY, Owensboro KY,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT06727552
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma